BRPI0612305A2 - moduladores de receptor de progesterona não-esteroidal - Google Patents

moduladores de receptor de progesterona não-esteroidal Download PDF

Info

Publication number
BRPI0612305A2
BRPI0612305A2 BRPI0612305-8A BRPI0612305A BRPI0612305A2 BR PI0612305 A2 BRPI0612305 A2 BR PI0612305A2 BR PI0612305 A BRPI0612305 A BR PI0612305A BR PI0612305 A2 BRPI0612305 A2 BR PI0612305A2
Authority
BR
Brazil
Prior art keywords
column
row
original document
document page
see original
Prior art date
Application number
BRPI0612305-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Ulrike Fuhrmann
Norbert Schmees
Ulrich Bothe
Wolfgang Schwede
Carsten Moeller
Anja Schmidt
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0612305A2 publication Critical patent/BRPI0612305A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88—Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
BRPI0612305-8A 2005-06-24 2006-06-22 moduladores de receptor de progesterona não-esteroidal BRPI0612305A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005030294.7 2005-06-24
DE102005030294A DE102005030294A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren
PCT/EP2006/006532 WO2006136462A1 (de) 2005-06-24 2006-06-22 Nonsteroidal progesterone receptor modulators

Publications (1)

Publication Number Publication Date
BRPI0612305A2 true BRPI0612305A2 (pt) 2010-11-03

Family

ID=36716643

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612305-8A BRPI0612305A2 (pt) 2005-06-24 2006-06-22 moduladores de receptor de progesterona não-esteroidal

Country Status (22)

Country Link
EP (1) EP1899315A1 (de)
JP (1) JP2008543911A (de)
KR (1) KR20080018275A (de)
CN (1) CN101248056A (de)
AR (1) AR057409A1 (de)
AU (1) AU2006261049A1 (de)
BR (1) BRPI0612305A2 (de)
CA (1) CA2611900A1 (de)
CR (1) CR9595A (de)
DE (1) DE102005030294A1 (de)
DO (1) DOP2006000150A (de)
EA (1) EA200702604A1 (de)
EC (1) ECSP078043A (de)
GT (1) GT200600272A (de)
IL (1) IL188022A0 (de)
MX (1) MX2008000070A (de)
NO (1) NO20080441L (de)
PE (1) PE20070170A1 (de)
TW (1) TW200738665A (de)
UY (1) UY29626A1 (de)
WO (1) WO2006136462A1 (de)
ZA (1) ZA200800689B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
TWI477276B (zh) 2008-04-28 2015-03-21 Repros Therapeutics Inc 抗黃體素給藥方案
MX363640B (es) 2012-05-31 2019-03-28 Repros Therapeutics Inc Formulaciones y metodos para la administracion vaginal de antiprogestinas.
AU2013338305B2 (en) 2012-11-02 2018-06-07 Allergan pharmaceuticals International Ltd. Methods and compositions for treating progesterone-dependent conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6358948B1 (en) * 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
WO2000066590A2 (en) * 1999-05-04 2000-11-09 Ligand Pharmaceuticals, Inc. Tetracyclic progesterone receptor modulator compounds and methods
WO2003059899A1 (en) * 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
JP2005526064A (ja) * 2002-03-11 2005-09-02 シエーリング アクチエンゲゼルシャフト 受精能制御およびホルモン置換療法における使用のためのプロゲステロン受容体調整活性を有する５−｛２−ヒドロキシ−３−１−（３−トリフルオロメチルフェニル）−シクロプロピル−プロピオニルアミノ｝−フタリドおよび関連化合物
DE10346939A1 (de) * 2003-10-06 2005-05-19 Schering Ag Heterocyclisch substituierte Pentanole, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Also Published As

Publication number Publication date
KR20080018275A (ko) 2008-02-27
PE20070170A1 (es) 2007-03-02
ECSP078043A (es) 2008-01-23
UY29626A1 (es) 2007-01-31
NO20080441L (no) 2008-03-07
MX2008000070A (es) 2008-03-19
DOP2006000150A (es) 2006-12-31
CN101248056A (zh) 2008-08-20
TW200738665A (en) 2007-10-16
EA200702604A1 (ru) 2008-06-30
AU2006261049A1 (en) 2006-12-28
CA2611900A1 (en) 2006-12-28
AR057409A1 (es) 2007-12-05
WO2006136462A1 (de) 2006-12-28
DE102005030294A1 (de) 2007-01-04
JP2008543911A (ja) 2008-12-04
GT200600272A (es) 2007-08-20
CR9595A (es) 2008-05-05
IL188022A0 (en) 2008-03-20
ZA200800689B (en) 2009-07-29
EP1899315A1 (de) 2008-03-19

Similar Documents

Publication Publication Date Title
AU749597B2 (en) Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US8053426B2 (en) Progesterone receptor antagonists
US6548491B2 (en) Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
BRPI0612305A2 (pt) moduladores de receptor de progesterona não-esteroidal
US6365582B1 (en) S-substitute 11β-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds
BRPI0611903A2 (pt) moduladores de receptor de progesterona não-esteroidal
JP4476480B2 (ja) 新規な１１β位が置換された１９−ノルステロイド、それらの製造方法及び中間体、それらの薬剤しての使用並びにそれらを含有する製薬組成物
Jovanović-Šanta et al. Evaluation of biological activity of new hemiesters of 17-hydroxy-16, 17-secoestra-1, 3, 5 (10)-triene-16-nitrile
US7408060B2 (en) Nonsteroidal progesterone receptor modulators
JP4509380B2 (ja) 新規の１７−ハロゲン化−１９−ノルステロイド、それらの製造方法及び中間体、それらの医薬としての使用並びにそれらを含有する製薬組成物
RU2137777C1 (ru) ПРОИЗВОДНЫЕ 11β-БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]